发明名称 BICYCLO 2,3-BENZODIAZEPINES AND SPIROCYCLICALLY SUBSTITUTED 2,3-BENZODIAZEPINES
摘要 The invention relates to BET protein-inhibiting, in particular BRD4-inhibiting, bicyclo 2,3-benzodiazepines and spirocyclically substituted 2,3-benzodiazepines of the general formula (I), to the pharmaceutical agents containing the compounds according to the invention, and to the prophylactic and therapeutic use thereof against hyper-proliferative diseases, in particular tumor diseases. The invention further relates to the use of BET protein inhibitors in benign hyperplasia, atherosclerotic diseases, sepsis, autoimmune diseases, vascular disorders, viral infections, neurodegenerative disorders, inflammatory disorders, and male fertility control.
申请公布号 WO2014128067(A1) 申请公布日期 2014.08.28
申请号 WO2014EP52984 申请日期 2014.02.17
申请人 BAYER PHARMA AKTIENGESELLSCHAFT 发明人 SIEGEL, STEPHAN;BÄURLE, STEFAN;CLEVE, ARWED;HAENDLER, BERNARD;FERNÁNDEZ-MONTALVÁN, AMAURY ERNESTO;MÖNNING, URSULA;KRAUSE, SABINE;LEJEUNE, PASCALE;BUSEMANN, MATTHIAS;KUHNKE, JOACHIM
分类号 C07D401/10;A61K31/551;A61P7/00;A61P25/28;A61P31/12;A61P35/00;A61P37/00;C07D403/10;C07D405/10;C07D451/06;C07D471/10;C07D487/04;C07D487/08;C07D487/10;C07D491/048 主分类号 C07D401/10
代理机构 代理人
主权项
地址